Lincoln Pharmaceuticals share price
You have to be logged in to add this to Watchlist.Lincoln Pharmaceuticals is trading -0.01% lower at Rs 617.45 as compared to its last closing price. Lincoln Pharmaceuticals has been trading in the price range of 644.90 & 611.00. Lincoln Pharmaceuticals has given 1.38% in this year & -1.86% in the last 5 days.
Lincoln Pharmaceuticals has TTM P/E ratio 13.89 as compared to the sector P/E of 33.29.
The company posted a net profit of 26.33 Crores in its last quarter.
Listed peers of Lincoln Pharmaceuticals include Vimta Labs (13.85%), Bliss Gvs Pharma (0.57%), Lincoln Pharmaceuticals (-0.01%) etc.
Lincoln Pharmaceuticals has a 50.22% public holding. The FII holding in Lincoln Pharmaceuticals was at 5.19% in 30 Sep 2024. The FII holding has increased from the last quarter.
Lincoln Pharmaceuticals share price range
|
| ||||
|
| ||||
Lincoln Pharmaceuticals share Key Metrics
| Market Cap ( ₹ Cr.) | 1,237.64 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Lincoln Pharmaceuticals Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 14-Nov-24 | Quarterly Results |
| 08-Aug-24 | Quarterly Results |
| 16-May-24 | Audited Results & Final Dividend |
| 08-Feb-24 | Quarterly Results |
| 02-Nov-23 | Quarterly Results |
| 10-Aug-23 | Quarterly Results |
| 25-May-23 | Audited Results & Dividend |
| 09-Feb-23 | Quarterly Results |
| 10-Nov-22 | Quarterly Results |
| 09-Aug-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 30-Sep-24 | 02-Sep-24 | AGM |
| 30-Sep-23 | 28-Aug-23 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 16-May-24 | - | 13-Sep-24 | 1.8 |
| 25-May-23 | - | 15-Sep-23 | 1.5 |
| 19-May-22 | - | 15-Sep-22 | 1.5 |
| 25-May-21 | - | 16-Sep-21 | 1.5 |
FAQs about Lincoln Pharmaceuticals share price
Lincoln Pharmaceuticals is trading at 617.45 as on Mon Nov 25 2024 09:58:00. This is -0.01% lower as compared to its previous closing price of 617.50.
The market capitalization of Lincoln Pharmaceuticals is 1237.64 Cr as on Mon Nov 25 2024 09:58:00.
The 52 wk high for Lincoln Pharmaceuticals is 814.00 whereas the 52 wk low is 498.00
Lincoln Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 13.89
- Sector P/E: 33.29
- Dividend Yield: 0.29%
- D/E ratio: 0.00
Lincoln Pharmaceuticals reported a net profit of 93.30 Cr in 2024.
Lincoln Pharmaceuticals Quick Links
Lincoln Pharmaceuticals Dividend Lincoln Pharmaceuticals Bonus Lincoln Pharmaceuticals News Lincoln Pharmaceuticals AGM Lincoln Pharmaceuticals Rights Lincoln Pharmaceuticals Splits Lincoln Pharmaceuticals Board Meetings Lincoln Pharmaceuticals Key Metrics Lincoln Pharmaceuticals Shareholdings Lincoln Pharmaceuticals Profit Loss Lincoln Pharmaceuticals Balance Sheet Lincoln Pharmaceuticals Cashflow Lincoln Pharmaceuticals Q1 Results Lincoln Pharmaceuticals Q2 Results Lincoln Pharmaceuticals Q3 Results Lincoln Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks